Skip to main content
. 2023 Jan 25;14(9):805–814. doi: 10.1111/1759-7714.14811

FIGURE 2.

FIGURE 2

Curve showing PFS (a) and OS (b) according to pretreatment PS in patients with extensive‐stage‐small‐cell lung cancer receiving carboplatin plus etoposide therapy (N = 63). OS, overall survival; PFS, progression‐free survival; PS, performance status